Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

DDIT3, OTUB2, and ASS1 regulate arginine biosynthesis in colorectal cancer cells under arginine deficiency.

Created on 11 Jul 2026

Authors

Mengying Li, Jie Zhang, Hui Zhang, Xiaolin Chen, Xiuqun Zou, Jiamin Wang, Wenyan Huang, Haixia Peng, Hao Jia, Zhaoyuan Hou

Published in

Cell reports. Volume 45. Issue 7. Pages 117621. Jul 09, 2026. Epub Jul 09, 2026.

Abstract

Argininosuccinate synthetase 1 (ASS1) is a rate-limiting enzyme in arginine biosynthesis, and its stability is regulated by TRAF2-mediated ubiquitination. Here, we report OTUB2 as a major deubiquitinase to stabilize ASS1, resulting increased arginine biosynthesis in colorectal cancer (CRC) cells; OTUB2 expression is elevated in CRC tissue, and patients with high OTUB2 expression exhibit shorter overall survival. As such, ectopic expression of OTUB2 promotes growth of CRC cells and xenograted tumors and accelerates cell migration and lung metastasis. Moreover, arginine deprivation induces marked expression of OTUB2 in CRC cells; mechanistically, arginine deprivation can activate AMPK, which in turn phosphorylates DDIT3, resulting its disassociation from C/EBPα and subsequent translocation into the cytoplasm and leading to increased binding of C/EBPα to the proximal promoter region of OTUB2 gene. Together, these data uncover a signaling pathway constituted of AMPK- DDIT3-C/EBPα-OTUB2-ASS1 to sense arginine deficiency and stimulate a metabolic compensatory pathway to sustain arginine homeostasis in CRC cells.

PMID:
42430238
Bibliographic data and abstract were imported from PubMed on 11 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement